臨床表現(xiàn)ppt課件-閱讀頁
2025-01-20 04:42本頁面
【正文】 normal LFTs 70%80%have no pathologic change in liver biopsy Diagnosis Clinical Data Epidemiological evidences Laboratory investigations Ultrasound Biopsy Differential diagnosis Jaundice caused by other etiological agents Hepatitis caused by other etiological agents Treatment Basic principles of management guideline for daily living, physical activity , food and drink intake of the patients supportive and symptomatic treatment Hepatic function protective agents Antivirus therapy most important treatment for chronic hepatitis B、 acute and chronic hepatitis C hepatitis B indication: HBVDNA ≥105copies/ml for HBeAg~, HBVDNA ≥104copies/ml for HBeAg+。 ALT ≥2ULN, or biopsy ≥G2S2 Drugs: interferonα(typical or pegylated) or, nucleotide analogues:3TC,adfovir, entecavir,Ldt… Hepatitis C indication: HCVRNA+ drugs: interferonα(typical or pegylated) +ribavirin Traditional Chinese medicine Management for liver failure basic supportive therapy treatment of plications bleeding infection plications encephalopathy renal failure Hepatic transplantation Management of asymptomatic HBV carrier medical check up periodically no any alcohol intake liver biopsy when patient’s age more than 40 years and HBV replication in high level Prevention Improvement of sanitation Blood screening of donors Antivirus treatment for hepatitis B and hepatitis C Immunoprophylaxis active immunization vaccines for hepatitis A and B are available around world, very successful for preexposure prevention passive immunization IG for hepatitis A, HBIG for hepatitis
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1